104 related articles for article (PubMed ID: 17970062)
1. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
Zhang TF; Yu SQ; Wang ZY
Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells.
Zhang TF; Yu SQ; Deuel TF; Wang ZY
Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
Li GC; Wang ZY
Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
[TBL] [Abstract][Full Text] [Related]
4. Inducible expression of RbAp46 activates c-Jun NH2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude mice.
Zhang TF; Yu SQ; Loggie BW; Wang ZY
Anticancer Res; 2003; 23(6C):4621-7. PubMed ID: 14981905
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of RbAp46 facilitates stress-induced apoptosis and suppresses tumorigenicity of neoplastigenic breast epithelial cells.
Li GC; Guan LS; Wang ZY
Int J Cancer; 2003 Jul; 105(6):762-8. PubMed ID: 12767060
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis.
Zhang X; Shen P; Coleman M; Zou W; Loggie BW; Smith LM; Wang Z
Anticancer Res; 2005; 25(1A):369-75. PubMed ID: 15816560
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma suppressor associated protein 46 (RbAp46) attenuates the beta-catenin/TCF signaling through up-regulation of GSK-3beta expression.
Li GC; Wang ZY
Anticancer Res; 2006; 26(6B):4511-8. PubMed ID: 17201172
[TBL] [Abstract][Full Text] [Related]
8. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
Chen GC; Guan LS; Yu JH; Li GC; Choi Kim HR; Wang ZY
Biochem Biophys Res Commun; 2001 Jun; 284(2):507-14. PubMed ID: 11394910
[TBL] [Abstract][Full Text] [Related]
9. SUMO-1 overexpression increases RbAp46 protein stability and suppresses cell growth.
Giri R; Yeh HH; Wu CH; Liu HS
Anticancer Res; 2008; 28(6A):3749-56. PubMed ID: 19189660
[TBL] [Abstract][Full Text] [Related]
10. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
11. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells.
Wang L; Wang ZY
Anticancer Res; 2008; 28(4B):2155-60. PubMed ID: 18751389
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer.
Thakur A; Rahman KW; Wu J; Bollig A; Biliran H; Lin X; Nassar H; Grignon DJ; Sarkar FH; Liao JD
Mol Cancer Res; 2007 Feb; 5(2):171-81. PubMed ID: 17314274
[TBL] [Abstract][Full Text] [Related]
15. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
16. Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.
den Hollander P; Rayala SK; Coverley D; Kumar R
Cancer Res; 2006 Nov; 66(22):11021-9. PubMed ID: 17108141
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
18. HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer.
Townson SM; Sullivan T; Zhang Q; Clark GM; Osborne CK; Lee AV; Oesterreich S
Clin Cancer Res; 2000 Sep; 6(9):3788-96. PubMed ID: 10999774
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
Harrell JC; Dye WW; Allred DC; Jedlicka P; Spoelstra NS; Sartorius CA; Horwitz KB
Cancer Res; 2006 Sep; 66(18):9308-15. PubMed ID: 16982776
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
